Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third-quarter 2025 dividend of $0.43 per share. Alongside these developments, ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential ...

That said, Pfizer Inc. (NYSE:PFE) has a five-year average payout ratio above 101%, which may seem alarming at first. A company can’t consistently pay more in dividends than it earns.

The Schwab U.S. Dividend Equity ETF yields around 4% today, which means that it would take an investment of approximately $50 ...

The dividend record date is when a company finalises eligible shareholders for dividend, e.g., if a company sets June 27, ...

Safe dividend-paying income stocks trading under $30 are passive income home runs. Stocks trading under the $30 level offer Boomers a larger share count when they buy. With the geopolitical ...

For this list, we're looking at U.S. stocks only that trade on major exchanges, with market caps of at least $10 billion. The ...

There is perhaps no better way to put a $500,000 windfall to work than to stash it in a self-directed investment portfolio.

The recent formation of the FIBRE Consortium, a collaboration involving Pfizer (NYSE:PFE) and other pharmaceutical partners, ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...